79 employees
IPA is a full-service, bioplatform-based and AI-driven company, specialized in next-gen antibody discovery for therapeutics.
1989
ImmunoPrecise Antibodies Ltd raised undisclosed on January 1, 1993
Investors: Brisio Innovations